| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 05/17/2011 | US7943363 Methods and compositions for improving the production of products in microorganisms |
| 05/17/2011 | US7943362 Biosynthesis of phloroglucinol and preparation of 1,3-dihydroxybenzene therefrom |
| 05/17/2011 | US7943360 Phospholipases, nucleic acids encoding them and methods for making and using them |
| 05/17/2011 | US7943358 Polymerase enhancing factor (PEF) extracts, PEF protein complexes, isolated PEF protein, and methods for purifying and identifying |
| 05/17/2011 | US7943351 Method for acyltransferase reaction using acyl coenzyme A |
| 05/17/2011 | US7943348 Method and apparatus for amplifying nucleic acids |
| 05/17/2011 | US7943345 Methods, systems and reagents for improved immunodetection |
| 05/17/2011 | US7943344 Hepatocyte growth factor (HGF) binding proteins |
| 05/17/2011 | US7943343 Production and use of novel peptide-based agents for use with bi-specific antibodies |
| 05/17/2011 | US7943342 Nucleic acids encoding IL-13 binding agents |
| 05/17/2011 | US7943339 Isolated nucleic acid molecules from the genome of citrus leprosis virus and uses thereof |
| 05/17/2011 | US7943338 Autoimmune conditions and NADPH oxidase defects |
| 05/17/2011 | US7943337 Method for screening a protease |
| 05/17/2011 | US7943322 Polynucleotides for use as tags and tag complements, manufacture and use thereof |
| 05/17/2011 | US7943316 Immunostimulatory oligonucleotides and uses thereof |
| 05/17/2011 | US7943307 Methods for analyzing nucleic acid sequences |
| 05/17/2011 | US7943305 High speed nucleic acid sequencing |
| 05/17/2011 | US7943303 Using site directed mutagenesis in transgenic microorganism to generate single-stranded nicking enzyme |
| 05/17/2011 | US7943302 C20ORF23 as modifier of the IGFR pathway and methods of use |
| 05/17/2011 | US7943300 Method for improved protein expression in bacteria by monitoring and modulating protein folding |
| 05/17/2011 | US7943179 Drug delivery particle; useful in genetic vaccination; eg poly(beta-amino esters) |
| 05/17/2011 | US7943149 Hepatitis C virus codon optimized non-structural NS3/4A fusion gene |
| 05/17/2011 | US7943144 Herpes simplex virus complex |
| 05/17/2011 | US7943129 Single-domain brain-targeting antibody fragments derived from llama antibodies |
| 05/17/2011 | US7943125 Attenuated gram negative bacteria |
| 05/17/2011 | US7943122 Attenuated bacteria useful in vaccines |
| 05/17/2011 | CA2576069C Detoxifizyme with activity of transforming aflatoxin and the gene encodes thereof |
| 05/17/2011 | CA2573257C Probe for detection and quantification of nitric oxide, and method for detecting and quantifying nitric oxide using the same |
| 05/17/2011 | CA2562335C Instrument for delivery of optical energy to the dental root canal system for hidden bacterial and live biofilm thermolysis |
| 05/17/2011 | CA2560844C Pharmaceutical agent containing hyaluronan as an active ingredient |
| 05/17/2011 | CA2558313C New expression tools for multiprotein applications |
| 05/17/2011 | CA2502785C Neisserial mutant strain lacking expression of a glycosyltransferase |
| 05/17/2011 | CA2462710C Polypeptide antigen forming a mimetic structure of the gp41 intermediate state |
| 05/17/2011 | CA2435917C Highly sensitive method for the detection of cytosine methylation patterns |
| 05/17/2011 | CA2415768C Method of producing functional protein domains |
| 05/17/2011 | CA2361943C Genetic modification of somatic cells and uses thereof |
| 05/17/2011 | CA2320100C High affinity nucleic acid ligands of complement system proteins |
| 05/17/2011 | CA2228221C Papillomavirus polyprotein constructs |
| 05/16/2011 | CA2723369A1 Association of the progesterone receptor with fertility |
| 05/12/2011 | WO2011057304A2 Microrna signatures differentiating uterine and ovarian papillary serous tumors |
| 05/12/2011 | WO2011057288A2 Isobutanol production with corynebacterium glutamicum |
| 05/12/2011 | WO2011057184A1 Stabilization of rna in and extracting from intact cells within a blood sample |
| 05/12/2011 | WO2011057171A1 METHODS FOR DELIVERY OF siRNA TO THE SPINAL CORD AND THERAPIES ARISING THEREFROM |
| 05/12/2011 | WO2011057163A2 Intein-modified enzymes, their production and industrial applications |
| 05/12/2011 | WO2011057160A2 Method to improve the immunogenicity of vaccine antigens by modification of cleavage sites in hiv-1 gp 120 |
| 05/12/2011 | WO2011057125A2 Compositions and methods for determining cancer susceptibility |
| 05/12/2011 | WO2011057120A1 Methods and composition for secretion of heterologous polypeptides |
| 05/12/2011 | WO2011057034A2 Catenae: serosal cancer stem cells |
| 05/12/2011 | WO2011056975A2 Genetically encoded calcium indicators and methods of use |
| 05/12/2011 | WO2011056971A2 Episomal reprogramming with chemicals |
| 05/12/2011 | WO2011056911A2 Compositions and methods for enhancing production of a biological product |
| 05/12/2011 | WO2011056899A2 Chimeric rsv-f polypeptide and lentivirus or alpha-retrovirus gag-based vlps |
| 05/12/2011 | WO2011056894A2 TRUNCATED EPIDERIMAL GROWTH FACTOR RECEPTOR (EGFRt) FOR TRANSDUCED T CELL SELECTION |
| 05/12/2011 | WO2011056886A2 Method and composition for generating programmed cell death resistant algal cells |
| 05/12/2011 | WO2011056866A2 Methods and kits for 3'-end-tagging of rna |
| 05/12/2011 | WO2011056771A2 Diagnostic assays for chordopoxviruses |
| 05/12/2011 | WO2011056769A1 Plants with improved nitrogen utilization and stress tolerance |
| 05/12/2011 | WO2011056644A2 Anti-glp-1r antibodies and their uses |
| 05/12/2011 | WO2011056544A1 Somatic ovule specific promoter and methods of use |
| 05/12/2011 | WO2011056300A1 Methods and compositions for modulating tau levels |
| 05/12/2011 | WO2011056222A1 Methods of treating disorders associated with protein aggregation |
| 05/12/2011 | WO2011056149A1 Resistant influenza a virus detection method and kit therefor |
| 05/12/2011 | WO2011056148A1 Muteins of the bacteriophage lambda integrases |
| 05/12/2011 | WO2011056060A2 Recombinant matrix protein of nipah virus |
| 05/12/2011 | WO2011056005A2 Novel sirna structure for minimizing off-target effects caused by antisense strands, and use thereof |
| 05/12/2011 | WO2011056004A2 Novel unidirectional xylose isomerase and method for production of d-glucose from mannose using the same |
| 05/12/2011 | WO2011055987A2 Method for screening of quorum sensing inhibitors |
| 05/12/2011 | WO2011055916A2 Method for detecting the methylation of colon-cancer-specific methylation marker genes for colon cancer diagnosis |
| 05/12/2011 | WO2011055897A9 Fusion protein binding specifically to constant region of antibody, preparation thereof and method for isolating antibody using the same |
| 05/12/2011 | WO2011055897A2 Fusion protein binding specifically to constant region of antibody, preparation thereof and method for isolating antibody using the same |
| 05/12/2011 | WO2011055880A1 Novel peptide promoting the expression of bdnf, and pharmaceutical composition including same for preventing and treating alzheimer's and parkinson's diseases |
| 05/12/2011 | WO2011055875A1 Thd primer target detection |
| 05/12/2011 | WO2011055851A1 Method of efficiently establishing induced pluripotent stem cells |
| 05/12/2011 | WO2011055737A1 Thermostable strand displacement dna polymerase and method for producing the dna polymerase |
| 05/12/2011 | WO2011055715A1 Hydroxy fatty acid analogues and method for producing same |
| 05/12/2011 | WO2011055710A1 Method for producing l-amino acid |
| 05/12/2011 | WO2011055366A1 Mo-1 conditional knock-out non-human animal and uses thereof |
| 05/12/2011 | WO2011055352A1 Induction of apomixis in sexually reproducing cultivated plants and use for producing totally or partially apomictic plants |
| 05/12/2011 | WO2011054994A1 Regulated expression systems |
| 05/12/2011 | WO2011054976A2 Novel viral vector construct for neuron specific optimized continuous dopa synthesis in vivo |
| 05/12/2011 | WO2011054939A2 Compositions and methods for inhibiting expression of kif10 genes |
| 05/12/2011 | WO2011054916A1 Methods and pharmaceutical composition for the treatment of atherosclerosis |
| 05/12/2011 | WO2011054899A1 Talaromyces transformants |
| 05/12/2011 | WO2011054811A1 Rna antagonists targeting hsp27 combination therapy |
| 05/12/2011 | WO2011054729A2 Amylopectin type starch with enhanced retrogradation stability |
| 05/12/2011 | WO2011054659A1 Exon skipping therapy for dysferlinopathies |
| 05/12/2011 | WO2011054150A1 Method of site-directed mutagenesis by overlapping pcr and use thereof in screening monoclonal antibody |
| 05/12/2011 | WO2011054112A1 Antibodies that specifically block the biological activity of kidney associated antigen 1 |
| 05/12/2011 | WO2011033375A3 Products and methods for enhanced transgene expression and processing |
| 05/12/2011 | WO2011033005A3 Cells for transient expression and uses thereof |
| 05/12/2011 | WO2011010337A9 Vaccines based on genetic chimera of viral and/or tumoral antigens and vegetable proteins |
| 05/12/2011 | WO2011008730A3 Chemical modification of small hairpin rnas for inhibition of gene expression |
| 05/12/2011 | WO2011005527A3 Ketoreductase-mediated stereoselective route to alpha chloroalcohols |
| 05/12/2011 | WO2011005496A3 Islet1 (isl1) and hearing loss |
| 05/12/2011 | WO2010151640A3 Compositions and methods for the diagnosis and treatment of inflammatory disorders and fibrotic disease |
| 05/12/2011 | WO2010148212A3 Short telomere length on chromosome 9p is strongly associated with breast cancer risk |
| 05/12/2011 | WO2010144908A3 Mammalian genes involved in tularemia and other infections |
| 05/12/2011 | WO2010144128A3 Molecular alignment and attachment of nucleic acid molecules |
| 05/12/2011 | WO2010139948A3 Method for incorporating aliphatic amino acids comprising alkyne, azide or aliphatic ketone functional groups using appropriate trna / trna synthase pairs |
| 05/12/2011 | WO2010138555A3 Small peptide expression system in mammalian cells |